Nantahala Capital Management, LLC 13D and 13G filings for Kiora Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:40 pm Purchase | 2026-03-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | Nantahala Capital Management, LLC | 438,469 9.990% | 74,757 (+20.55%) | Filing |
| 2025-11-14 4:31 pm Purchase | 2025-09-30 | 13G | KIORA PHARMACEUTICALS INC KPRX | Nantahala Capital Management, LLC | 363,712 9.990% | 57,450 (+18.76%) | Filing |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | KIORA PHARMACEUTICALS INC KPRX | Nantahala Capital Management, LLC | 306,262 9.990% | 306,262 (New Position) | Filing |